These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 20717628)

  • 1. A general glycomimetic strategy yields non-carbohydrate inhibitors of DC-SIGN.
    Garber KC; Wangkanont K; Carlson EE; Kiessling LL
    Chem Commun (Camb); 2010 Sep; 46(36):6747-9. PubMed ID: 20717628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unique DC-SIGN clustering activity of a small glycomimetic: A lesson for ligand design.
    Sutkeviciute I; Thépaut M; Sattin S; Berzi A; McGeagh J; Grudinin S; Weiser J; Le Roy A; Reina JJ; Rojo J; Clerici M; Bernardi A; Ebel C; Fieschi F
    ACS Chem Biol; 2014 Jun; 9(6):1377-85. PubMed ID: 24749535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Noncarbohydrate glycomimetics and glycoprotein surrogates as DC-SIGN antagonists and agonists.
    Prost LR; Grim JC; Tonelli M; Kiessling LL
    ACS Chem Biol; 2012 Sep; 7(9):1603-8. PubMed ID: 22747463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monovalent mannose-based DC-SIGN antagonists: targeting the hydrophobic groove of the receptor.
    Tomašić T; Hajšek D; Švajger U; Luzar J; Obermajer N; Petit-Haertlein I; Fieschi F; Anderluh M
    Eur J Med Chem; 2014 Mar; 75():308-26. PubMed ID: 24556146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pseudosaccharide functionalized dendrimers as potent inhibitors of DC-SIGN dependent Ebola pseudotyped viral infection.
    Luczkowiak J; Sattin S; Sutkevičiūtė I; Reina JJ; Sánchez-Navarro M; Thépaut M; Martínez-Prats L; Daghetti A; Fieschi F; Delgado R; Bernardi A; Rojo J
    Bioconjug Chem; 2011 Jul; 22(7):1354-65. PubMed ID: 21650462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New lipophilic glycomimetic DC-SIGN ligands: Stereoselective synthesis and SPR-based binding inhibition assays.
    Di Pietro S; Bordoni V; Iacopini D; Achilli S; Pineschi M; Thépaut M; Fieschi F; Crotti P; Di Bussolo V
    Bioorg Chem; 2021 Feb; 107():104566. PubMed ID: 33387733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rational-Differential Design of Highly Specific Glycomimetic Ligands: Targeting DC-SIGN and Excluding Langerin Recognition.
    Porkolab V; Chabrol E; Varga N; Ordanini S; Sutkevičiu Tė I; Thépaut M; García-Jiménez MJ; Girard E; Nieto PM; Bernardi A; Fieschi F
    ACS Chem Biol; 2018 Mar; 13(3):600-608. PubMed ID: 29272097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Facile access to pseudo-thio-1,2-dimannoside, a new glycomimetic DC-SIGN antagonist.
    Tamburrini A; Achilli S; Vasile F; Sattin S; Vivès C; Colombo C; Fieschi F; Bernardi A
    Bioorg Med Chem; 2017 Oct; 25(19):5142-5147. PubMed ID: 28389114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Second generation of fucose-based DC-SIGN ligands: affinity improvement and specificity versus Langerin.
    Andreini M; Doknic D; Sutkeviciute I; Reina JJ; Duan J; Chabrol E; Thepaut M; Moroni E; Doro F; Belvisi L; Weiser J; Rojo J; Fieschi F; Bernardi A
    Org Biomol Chem; 2011 Aug; 9(16):5778-86. PubMed ID: 21735039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-carbohydrate inhibitors of the lectin DC-SIGN.
    Borrok MJ; Kiessling LL
    J Am Chem Soc; 2007 Oct; 129(42):12780-5. PubMed ID: 17902657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human seminal plasma abrogates the capture and transmission of human immunodeficiency virus type 1 to CD4+ T cells mediated by DC-SIGN.
    Sabatté J; Ceballos A; Raiden S; Vermeulen M; Nahmod K; Maggini J; Salamone G; Salomón H; Amigorena S; Geffner J
    J Virol; 2007 Dec; 81(24):13723-34. PubMed ID: 17913809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multivalent manno-glyconanoparticles inhibit DC-SIGN-mediated HIV-1 trans-infection of human T cells.
    Martínez-Avila O; Bedoya LM; Marradi M; Clavel C; Alcamí J; Penadés S
    Chembiochem; 2009 Jul; 10(11):1806-9. PubMed ID: 19565596
    [No Abstract]   [Full Text] [Related]  

  • 13. High-affinity glycopolymer binding to human DC-SIGN and disruption of DC-SIGN interactions with HIV envelope glycoprotein.
    Becer CR; Gibson MI; Geng J; Ilyas R; Wallis R; Mitchell DA; Haddleton DM
    J Am Chem Soc; 2010 Nov; 132(43):15130-2. PubMed ID: 20932025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrin/CD209 is abundant on macrophages in the normal human lymph node and is not required for dendritic cell stimulation of the mixed leukocyte reaction.
    Granelli-Piperno A; Pritsker A; Pack M; Shimeliovich I; Arrighi JF; Park CG; Trumpfheller C; Piguet V; Moran TM; Steinman RM
    J Immunol; 2005 Oct; 175(7):4265-73. PubMed ID: 16177066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Designing nanomolar antagonists of DC-SIGN-mediated HIV infection: ligand presentation using molecular rods.
    Ordanini S; Varga N; Porkolab V; Thépaut M; Belvisi L; Bertaglia A; Palmioli A; Berzi A; Trabattoni D; Clerici M; Fieschi F; Bernardi A
    Chem Commun (Camb); 2015 Mar; 51(18):3816-9. PubMed ID: 25648900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DC-SIGN antagonists, a potential new class of anti-infectives.
    Anderluh M; Jug G; Svajger U; Obermajer N
    Curr Med Chem; 2012; 19(7):992-1007. PubMed ID: 22257062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of DC-SIGN-mediated HIV infection by a linear trimannoside mimic in a tetravalent presentation.
    Sattin S; Daghetti A; Thépaut M; Berzi A; Sánchez-Navarro M; Tabarani G; Rojo J; Fieschi F; Clerici M; Bernardi A
    ACS Chem Biol; 2010 Mar; 5(3):301-12. PubMed ID: 20085340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short Communication: Inhibition of DC-SIGN-Mediated HIV-1 Infection by Complementary Actions of Dendritic Cell Receptor Antagonists and Env-Targeting Virus Inactivators.
    Pustylnikov S; Dave RS; Khan ZK; Porkolab V; Rashad AA; Hutchinson M; Fieschi F; Chaiken I; Jain P
    AIDS Res Hum Retroviruses; 2016 Jan; 32(1):93-100. PubMed ID: 26383762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An assay for functional dendritic cell-specific ICAM-3-grabbing nonintegrin (DC-SIGN) inhibitors of human dendritic cell adhesion.
    Obermajer N; Svajger U; Jeras M; Sattin S; Bernardi A; Anderluh M
    Anal Biochem; 2010 Nov; 406(2):222-9. PubMed ID: 20667443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective targeting of dendritic cell-specific intercellular adhesion molecule-3-grabbing nonintegrin (DC-SIGN) with mannose-based glycomimetics: synthesis and interaction studies of bis(benzylamide) derivatives of a pseudomannobioside.
    Varga N; Sutkeviciute I; Guzzi C; McGeagh J; Petit-Haertlein I; Gugliotta S; Weiser J; Angulo J; Fieschi F; Bernardi A
    Chemistry; 2013 Apr; 19(15):4786-97. PubMed ID: 23417900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.